Dec 10, 2025 08:30AM
Dec 10, 2025 08:30AM
Oct 23, 2025 08:00AM
Aug 28, 2025 08:30AM
Jun 20, 2025 09:20AM
Jun 20, 2025 09:20AM
Jun 16, 2025 04:20PM Form S-1/A Moleculin Biotech, Inc.
Jun 11, 2025 05:30PM
Jun 6, 2025 09:21AM
Jun 2, 2025 05:16PM
Mar 31, 2025 05:04PM
Feb 13, 2025 01:07PM
Feb 13, 2025 01:05PM
Feb 11, 2025 08:32AM Form S-1/A Moleculin Biotech, Inc.
Feb 10, 2025 08:32AM
Jan 29, 2025 09:19AM
Dec 13, 2024 05:02PM
Aug 19, 2024 04:05PM
Aug 16, 2024 08:00AM
Aug 16, 2024 08:00AM
Aug 15, 2024 11:21AM Form S-1/A Moleculin Biotech, Inc.
Aug 15, 2024 06:16AM
Aug 14, 2024 08:05AM
Jul 30, 2024 07:01AM
Jul 22, 2024 05:32PM
Feb 2, 2024 05:06PM
Oct 25, 2018 06:01AM
Oct 15, 2018 05:03PM Form S-1 Moleculin Biotech, Inc.
Jul 12, 2018 04:30PM
May 15, 2018 06:15PM
Apr 11, 2018 05:10PM
Mar 22, 2017 09:37AM
Mar 22, 2017 09:35AM
Mar 10, 2017 07:30AM
Feb 9, 2017 09:14AM Moleculin Biotech (MBRX) Prices 3.71M Unit Offering at $1.35
Feb 9, 2017 09:09AM
Feb 8, 2017 04:39PM
Feb 7, 2017 10:30AM
Jan 19, 2017 07:00AM
Jan 18, 2017 08:32AM
Dec 13, 2016 07:31AM
Dec 13, 2016 07:30AM Moleculin Presents Preclinical Data of Novel Inhibitor of Glycolysis at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Dec 2, 2016 05:27PM
Nov 21, 2016 07:30AM
Nov 17, 2016 07:31AM
Nov 17, 2016 07:30AM
Oct 26, 2016 08:19AM
Oct 26, 2016 08:00AM
Oct 20, 2016 08:00AM Moleculin Announces Reminder for Conference Call to Discuss Positive Developments Regarding Annamycin
Oct 17, 2016 08:00AM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All